ScanSource (SCSC) Earnings Analysis
ScanSource (SCSC) next reports earnings on 2026-08-20, consensus EPS 1.11 USD. Last quarter (2026-05-07) it beat with EPS 0.94 USD vs 0.91 USD est (+3.3%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 16.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SCSC next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | 1.11 USD |
| Revenue estimate | 0.81B |
SCSC earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.94 USD | 0.91 USD | +3.3% | Beat |
| 2026-02-05 | 0.8 USD | 1 USD | -20% | Miss |
| 2025-11-06 | 1.06 USD | 0.91 USD | +16.5% | Beat |
| 2025-08-21 | 1.02 USD | 0.91 USD | +12.1% | Beat |
| 2025-01-30 | 0.85 USD | 0.89 USD | -4.5% | Miss |
| 2024-11-07 | 0.84 USD | 0.78 USD | +7.7% | Beat |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
SCSC valuation and analyst view
| Trailing P/E | 16.61 |
|---|---|
| Trailing EPS | 3.443 USD |
| Price / book | 1.29 |
| Dividend yield | 0.00% |
| Market cap | 1.11B |
| Analyst consensus | Hold (0 buy / 5 hold / 0 sell) |
| Avg price target | 43 USD |
Related research pages
Frequently asked questions
When is ScanSource (SCSC)'s next earnings date?
ScanSource is next scheduled to report on 2026-08-20, with a consensus EPS estimate of 1.11 USD and revenue estimate of 0.81B.
Did SCSC beat earnings last quarter?
In its 2026-05-07 report, SCSC posted EPS of 0.94 USD versus a 0.91 USD estimate — a beat of 3.3%.
What is SCSC's earnings track record?
Over the last 6 reported quarters with consensus data, SCSC beat estimates 4 times (67%).
What is SCSC's current P/E ratio and EPS?
SCSC trades at a trailing P/E of 16.61 on trailing EPS of 3.4426660408354848 USD.
What do analysts rate SCSC?
Analyst consensus is "Hold" across 5 ratings (0 strong buy, 0 buy, 5 hold, 0 sell, 0 strong sell). Average 12-month price target: 43 USD.